PRODUCT DETAIL

Co-Prenessa Neo 10 mg/2,5 mg tablety

Code

9539D

MA number

58/0024/22-S

Product Form:

tbl 60x10 mg/2,5 mg (blis.OPA/Al/PVC//Al)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

Therapeutic Class:

58 - HYPOTENSIVA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09B	ACE INHIBITORS, COMBINATIONS
C09BA	ACE inhibitors and diuretics
C09BA04	Perindopril and diuretics

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	04.02.2022
Validity:	04.02.2027
Pediatric warnings:	Yes
PIL:	PIL_Co-Prenessa Neo_04/2023.pdf
SPC:	SPC_Co-Prenessa Neo 10 mg/2,5 mg_04/2023.pdf
Safety feature	Yes
Data update:	04.02.2022